EQS-Adhoc

IGEA announces extraordinary general meeting results - Seite 2

IGEA is listed on the SIX Swiss Exchange (ticker IGPH) and is headquartered in Hoofddorp, the Netherlands. Find out more at www.igeapharma.nl

Contacts
Vincenzo Moccia, CEO, [phone], [e-mail]

Disclaimer
This document constitutes neither an offer to buy nor to subscribe securities and neither this document nor any part of it should form the basis of any investment decision in IGEA. The information contained in this press release has been carefully prepared. However, IGEA bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. IGEA does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons. This publication may contain specific forward-looking statements and assessments or intentions concerning IGEA and its business. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of IGEA and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. IGEA assumes no responsibility to update forward looking statements or to adapt them to future events or developments, except as may be required by law.

Additional features:


File: 20210428 igea nv_press release

---

End of ad hoc announcement

---

Language:	English
Company:	IGEA Pharma N.V.
	Siriusdreef 17
	2123 WT Hoofddorp
	Netherlands
Phone:	[phone]
E-mail:	[e-mail]
Internet:	www.igeapharma.nl
ISIN:	NL0012768675
Listed:	Regulated Unofficial Market in Frankfurt; BX Berne eXchange; SIX Swiss Exchange
EQS News ID:	1190232